Georgia's Online Cancer Information Center

Find A Treatment Site

Oncology Research at Peyton Anderson Cancer Center, Navicent Health

The Peyton Anderson Cancer Center is located at 800 First Street, Macon, Georgia. Visitors to the Peyton Anderson Health Center will find warm, friendly staff providing patient focused care.

Everything about us is all about you.

 

Among the services you will find at The Peyton Anderson Cancer Center, Navicent Health are:

  • PET/CT Center,Navicent Health            (478) 633-4738
  • Breast Care Center, Navicent Health     (478) 633-7020
  • Central Georgia Cancer Care                (478) 743-7068
  • Infusion Services, Navicent Health        (478) 633-8811
  • Central Georgia Radiation Oncology     (478) 743-3466
  • Surgical Oncology                                  (478) 633-6900
  • Gynecologic Oncology                           (478) 633-6090
  • Genetic Counselor                                 (478) 633-6900
  • Navigators
  • Reading Room
  • Meditation Room

 

 

Treatment Sites in Georgia

Primary Location

800 1st Street
Macon, GA 31201
478-633-2152 (p)
478-633-8894 (f)
www.navicenthealth.org

driving directions


Central Georgia Cancer Care

800 First Street
Suite 410
Macon, 31201
478 633-2152 (p)
(478) 633-8894 (f)


driving directions


Central Georgia Cancer Care

114 Sutherlin Drive
Suite C-1
Warner Robins, 31088
(478) 633-2152 (p)
(478) 633-8894 (f)


driving directions

Clinical Trials in Georgia

A Phase II Study of MEDI4736 (Durvalumab) plus Tremelimumab as Therapy for Patients with Previously Treated Anti-PD-1 / PD-L1 Resistant Stage IV Squamous Cell Lung Cancer (Lung-Map Non-Match Sub-Study)
Cancer Type: Unspecified

A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Placebo for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Cancer Type: Lung Cancer
Study Coordinator: Andrew Weatherall - (478) 633-2152


A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial
Cancer Type: Breast Cancer

A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy vs. Observation in Patients with Residual Triple-Negative Basal-like Breast Cancer following Neoadjuvant Chemotherapy
Cancer Type: Breast Cancer
Study Coordinator: Andrew Weatherall - (478) 633-2152


Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Cancer Type: Lung Cancer
Study Coordinator: Andrew Weatherall - (478)633-2152


EAY131: Molecular Analysis for Therapy Choice (NCI-MATCH)
Cancer Type: Eye Cancer, Lymphoma, Multiple Primaries, Non-Hodgkin Lymphoma, Solid Tumor, Unknown Primary
Study Coordinator: Andrew Weatherall - 4786332152


Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
Cancer Type: Lung Cancer
Study Coordinator: Kristin Spradlin - (478) 633-1738


Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered With Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck
Cancer Type: Oral Cancer
Study Coordinator: Kristin Spradlin - 478 633-1738


Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Cancer Type: Breast Cancer
Study Coordinator: Andrew Weatherall or Kristin Spradlin - 4786332152
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.